World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Netherlands
2023

D-Index & Metrics

Genetics

D-Index
117
Citations
89793
World Ranking
418
National Ranking
14

Medicine

D-Index
120
Citations
95189
World Ranking
3652
National Ranking
141

René Bernards publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where René Bernards sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 436 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

René Bernards D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where René Bernards sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 117 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Netherlands Leader Award
  • 2020 - Member of the National Academy of Sciences
  • 2019 - Fellow of the American Academy of Arts and Sciences
  • 2007 - Royal Netherlands Academy of Arts and Sciences
  • 2005 - Member of Academia Europaea
  • 2005 - Spinoza Prize, Dutch Research Council
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

René Bernards is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands, focusing primarily on biochemistry, genetics, and molecular biology. Their work spans 153 publications in these fields, with a significant emphasis on medicine, represented by 115 publications.

The research contributions are concentrated in several subfields, including molecular biology, oncology, pulmonary and respiratory medicine, cancer research, and physiology. This multidisciplinary approach supports investigations into complex biological processes and disease mechanisms.

The main topics covered by their research include:

  • Telomeres, Telomerase, and Senescence
  • Ubiquitin and proteasome pathways
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • CRISPR and Genetic Engineering
  • Protein Degradation and Inhibitors
  • PI3K/AKT/mTOR signaling in cancer

René Bernards has contributed to numerous recent scientific papers, such as:

  • Exploiting senescence for the treatment of cancer, 2022, Nature Reviews Cancer
  • Evolving therapeutic landscape of advanced hepatocellular carcinoma, 2022, Nature Reviews Gastroenterology & Hepatology
  • EGFR activation limits the response of liver cancer to lenvatinib, 2021, Nature
  • Rational combinations of targeted cancer therapies: background, advances and challenges, 2022, Nature Reviews Drug Discovery
  • Embracing cancer complexity: Hallmarks of systemic disease, 2024, Cell

Frequent collaborators in their research include Roderick L. Beijersbergen, Cor Lieftink, Wenxin Qin, Liqin Wang, and Fleur Jochems. Their work also appears regularly in several scientific venues, with multiple publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Oncology
  • Cancer Research
  • Proceedings of the National Academy of Sciences
  • Nature Cancer

Throughout their career, René Bernards has received recognition through a variety of awards and memberships, including:

  • Member of the National Academy of Sciences, 2020
  • Fellow of the American Academy of Arts and Sciences, 2019
  • Royal Netherlands Academy of Arts and Sciences, 2007
  • Member of Academia Europaea, 2005
  • Spinoza Prize, Dutch Research Council, 2005
  • Member of the European Molecular Biology Organization (EMBO)

Best Publications

  • Gene expression profiling predicts clinical outcome of breast cancer

    Laura J. van 't Veer;Hongyue Dai;Marc J. van de Vijver;Yudong D. He

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

    Thijn R. Brummelkamp;René Bernards;Reuven Agami

  • The consensus molecular subtypes of colorectal cancer

    Justin Guinney;Rodrigo Dienstmann;Rodrigo Dienstmann;Xingwu Wang;Xingwu Wang;Aurélien De Reyniès

  • A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

    Stephen H. Friend;Stephen H. Friend;Rene Bernards;Snezna Rogelj;Robert A. Weinberg

  • Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

    Anirudh Prahallad;Chong Sun;Sidong Huang;Federica Di Nicolantonio

  • A Genomic and Functional Inventory of Deubiquitinating Enzymes

    Sebastian M.B. Nijman;Mark P.A. Luna-Vargas;Arno Velds;Thijn R. Brummelkamp

  • A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

    Katrien Berns;Hugo M. Horlings;Bryan T. Hennessy;Mandy Madiredjo

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • Stable suppression of tumorigenicity by virus-mediated RNA interference.

    Thijn R Brummelkamp;René Bernards;Reuven Agami

  • A large-scale RNAi screen in human cells identifies new components of the p53 pathway

    Katrien Berns;E. Marielle Hijmans;Jasper Mullenders;Thijn R. Brummelkamp

  • Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB

    Thijn R. Brummelkamp;Sebastian M. B. Nijman;Annette M. G. Dirac;René Bernards

  • An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.

    Katherine Stemke-Hale;Ana Maria Gonzalez-Angulo;Ana Lluch;Richard M. Neve

  • A progression puzzle.

    René Bernards;Robert A. Weinberg

  • Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

    Chong Sun;Liqin Wang;Sidong Huang;Guus J. J. E. Heynen

  • CDK-Independent Activation of Estrogen Receptor by Cyclin D1

    Renate M.L Zwijsen;Ellen Wientjens;Rob Klompmaker;Jeroen van der Sman

  • The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

    Benjamin D. Rowland;René Bernards;Daniel S. Peeper

  • Enabling personalized cancer medicine through analysis of gene-expression patterns

    Laura J. van 't Veer;René Bernards

  • The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway

    Sebastian M.B. Nijman;Tony T. Huang;Annette M.G. Dirac;Thijn R. Brummelkamp

  • Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

    Roderik M. Kortlever;Paul J. Higgins;René Bernards

Frequent Co-Authors

Roderick L. Beijersbergen
Roderick L. Beijersbergen Antoni van Leeuwenhoek Hospital
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Carlos Caldas
Carlos Caldas University of Cambridge
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Thijn R. Brummelkamp
Thijn R. Brummelkamp Antoni van Leeuwenhoek Hospital
Suet-Feung Chin
Suet-Feung Chin University of Cambridge
Stephen H. Friend
Stephen H. Friend Sage Bionetworks
A. J. Van Der Eb
A. J. Van Der Eb Leiden University
Mauro Delorenzi
Mauro Delorenzi University of Lausanne
Marc J. van de Vijver
Marc J. van de Vijver University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Genetics, numerous online education options can help kickstart your career or allow you to specialize further. Areas such as online medical billing and coding offer entry into healthcare fields with flexible learning schedules and practical job prospects.

For those eager to join the workforce quickly, accelerated career programs provide opportunities to earn your credentials faster than traditional routes. These fast-track options are ideal for highly motivated students or working professionals aiming to pivot their career paths efficiently.

Flexibility is another key factor in choosing the right program. Many accredited schools now offer online self paced college courses, letting you balance studies with personal responsibilities. Such courses empower you to learn at your own speed, making advanced study in Genetics more accessible.

Cost and accessibility are also crucial considerations. Today, several online colleges with free applications help lower initial barriers, making it easier for more students to start or continue their educational journeys in genetics or related health science careers.

Best Scientists Citing René Bernards

Trending Scientists

Recently Published Articles